EARLY DEVELOPMENT OF ACUTE MYELOGENOUS LEUKEMIA FOLLOWING KIDNEY-TRANSPLANTATION - POSSIBLE ROLE OF MULTIPLE SERUM CYTOKINES

被引：5

作者：

BURKE, GW

CIROCCO, R

MARKOU, M

TEMPLE, JD

ALLOUCH, M

ROTH, D

NERY, J

MILLER, J

机构：

[1] University of Miami, Department of Surgery, Division of Transplantation, Department of Medicine, Miami Veterans Administration Hospital, Miami, FL

来源：

LEUKEMIA & LYMPHOMA | 1995年 / 19卷 / 1-2期

关键词：

ACUTE MYELOGENOUS LEUKEMIA; KIDNEY TRANSPLANTATION; CYTOKINES; INTERLEUKIN-1; INTERLEUKIN-2; INTERLEUKIN-2R; INTERLEUKIN-3; INTERLEUKIN-4; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; GMCSF; CYCLOSPORINE A;

D O I：

10.3109/10428199509059673

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We report a patient who at the time of kidney transplantation for polycystic kidney disease was found to have an enlarged inguinal lymph node which later demonstrated evidence of extra medullary granulopoiesis. During the first two weeks following kidney transplantation, a striking leukemoid pattern developed and 2 months after transplant the patient was diagnosed with acute myelogenous leukemia (AML). Retrospective analysis of peripheral blood cytokines over this time revealed elevated levels of GMCSF and gamma IFN at the time of peak peripheral blood WBC with subsequent peaks in IL-4, IL-6 and IL-2 as the peripheral blood WBC fell. A rise in levels of TNF alpha also preceded the peripheral blood WBC rise (although these concentrations were at or below those following uncomplicated kidney transplants). The clinical course of AML in this patient was marked by relentless relapse despite chemotherapy. The possibility of cytokine facilitated tumor growth is discussed.

引用

页码：173 / 180

页数：8

共 44 条

[31]

Lowry R.P., The relationship of IL-4. IL-10 and other cytokines to transplantation tolerance, Transplantation Sci., 3, pp. 104-112, (1993)

[32]

Paliogianni F., Ahuja S.S., Balow J.P., Balow J.E., Boumpas D.T., Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor, J. Immunology, 151, 8, pp. 4081-4089, (1993)

[33]

Benjamin D., Knobloch T.J., Dayton M.A., Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10, Blood, 80, 5, pp. 1289-1298, (1992)

[34]

Penn I., The effect of immunosuppression on preexisting cancers, Transplantation, 55, 4, pp. 742-747, (1993)

[35]

Barrett W.L., First M.R., Aron B.S., Penn I., Clinical course of malignancies in renal transplant recipients, Cancer, 72, pp. 2186-2189, (1993)

[36]

Streilein J.W., Taylor J.R., Vincek V., Immune surveillance and sunlight-induced skin cancer, Immunology Today., 15, 4, pp. 174-179, (1994)

[37]

Yefenof E., Abboud G., Epszteyn S., Vitetta E.S., Treatment of premalignancy: Prevention of lymphoma in radiation leukemia virus-inoculated mice by cyclosporin A and immunotoxin, Proc, Nail. Acad Sci. USA, 89, pp. 728-732, (1992)

[38]

Forster E., Kirnbauer R., Urbanski A., Et al., Human melanoma cells produce interleukin 8 which functions as an autocrine growth factor, Clin, Res., 39, (1991)

[39]

Richmond A., The pathogenic role of growth factors in melanoma, Semin, Dermatol., 10, pp. 246-255, (1991)

[40]

Gnss H.J., Brach M.A., Drexler H.G., Bross K.J., Herrman F., Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells, Cancer Res., 52, pp. 1026-1031, (1992)

← 1 2 3 4 5 →